Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (291-300 of 706) with videos related to

Pageof 71
Sort By:
Clinical Cardiology|February 7, 2015
Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot studyGrant W Reed, Amit Kumar, Jianping Guo, et al.
The American Journal of Cardiology|January 27, 2005
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapyAjay J Kirtane, Ioanna Kosmidou, Dimitrios Karmpaliotis, et al.
The American Journal of Cardiology|September 22, 2007
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)Sabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.
European Heart Journal|April 4, 2007
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18Kausik K Ray, Christopher P Cannon, David A Morrow, et al.
Journal of Thrombosis and Thrombolysis|January 16, 2007
Heparin resistance in acute coronary syndromesJonathan D Rich, John M Maraganore, Edward Young, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Early angiography in patients with chronic kidney disease: a collaborative systematic reviewDavid M Charytan, Lars Wallentin, Bo Lagerqvist, et al.
JACC. Clinical Electrophysiology|May 26, 2018
A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU TrialMatthew R Reynolds, J Scott Allison, Andrea Natale, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
Critical Pathways in Cardiology|May 7, 2009
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH RegistryKim A Eagle, Alan T Hirsch, Robert M Califf, et al.
Pageof 71

Showing results (291-300 of 706) with videos related to

Sort By:
Pageof 71
Clinical Cardiology|February 7, 2015
Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot studyGrant W Reed, Amit Kumar, Jianping Guo, et al.
The American Journal of Cardiology|January 27, 2005
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapyAjay J Kirtane, Ioanna Kosmidou, Dimitrios Karmpaliotis, et al.
The American Journal of Cardiology|September 22, 2007
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)Sabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.
European Heart Journal|April 4, 2007
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18Kausik K Ray, Christopher P Cannon, David A Morrow, et al.
Journal of Thrombosis and Thrombolysis|January 16, 2007
Heparin resistance in acute coronary syndromesJonathan D Rich, John M Maraganore, Edward Young, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Early angiography in patients with chronic kidney disease: a collaborative systematic reviewDavid M Charytan, Lars Wallentin, Bo Lagerqvist, et al.
JACC. Clinical Electrophysiology|May 26, 2018
A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU TrialMatthew R Reynolds, J Scott Allison, Andrea Natale, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
Critical Pathways in Cardiology|May 7, 2009
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH RegistryKim A Eagle, Alan T Hirsch, Robert M Califf, et al.
Pageof 71